DMG.H.V - DMD Digital Health Connections Group Inc

[midard]

DMD permet aux entreprises pharmaceutiques, biotechnologiques et de dispositifs médicaux d’atteindre, de faire la publicité à, et d’interagir efficacement avec des professionnels de soins de santé via l’Internet, DMD est une entreprise qui offrent des services de marketing dans le domaine des soins de santé et qui permet d’avoir accès à des professionnels en soins de santé, y compris médecins, pharmaciens, infirmiers et autres professionnels de santé connexes à travers les canaux de courrier direct et de courriel.

D’après les derniers documents déposé sur SEDAR, l’entreprise est cash flow positive et a eu des revenues de 14.3 millions pour les 6 premiers mois de l’année. DMD a fait des profits de 3.8 million au dernier trimestre et s’en est servi pour éteindre une dette de 3.1 million. C’est un titre qui a des revenues principalement en dollard Américain donc peut-être sensible au variation du dollar Canadien. Voici le dernier rapport trimestrielle
Leur marge brute est excellente , je crois que ce titre peut facilement doubler d’ici la fin de l’année.
Site web de l’entreprise
Entrevue avec Joe Mastracchio au Epharma summit 2014
Entrevue avec Roger Korman au Epharma summit 2013

Beaucoup d’achat d’initiés dernièrement
Director Roger Korman acquired 111,000 shares of the company’s stock in a transaction dated Monday, August 31st. The shares were purchased at an average price of C$0.21 per share, for a total transaction of C$23,310.00.
La charte ci-dessous est aussi positive.

[midard]

Si vous voulez faire des recherches sur SEDAR a propos de cette entreprise, rechercher Groupe DMD connexions santé numériques inc

[midard]

Reltio Cloud delivers data-as-a-service (DaaS) Comme on peut voir dans la page web ci-contre, la compagnie DMD possède une immense base de donné qui couvrent les médecins et les professionnels de la santé aux Etats-Unis. Les grosse compagnies pharmaceutiques utilisent leurs services pour promouvoir et renseigner les personnes concernés avec un modèle (DaaS) data-as-a-service.

Author5 First and Last Name
Mark Gleason · April 6, 2015 · DMD

MARK PLEASE TELL OUR READERS A LITTLE SOMETHING ABOUT YOURSELF

I’ve been very involved, particularly with early stage companies, enabling them to succeed through the innovative use of technology. Throughout my career I have participated in breakthrough products in areas such as eDetailing, eSampling and live video detailing, as they have evolved to be common place in pharmaceutical marketing jargon and practice. Our latest offering is the evolution of staid email services into a virtual census-level, state-of-the art digital service with incredible intelligence built in. I’m both the COO and chief product developer for DMD.

WHAT MAKES DMD UNIQUE?

DMD delivers the tools that has transformed traditional medical publishers into competitive digital publishers. We provide a direct connection to healthcare professionals (HCPs) that allows our platform to support digital innovation. DMD’s system allows healthcare professionals to opt-in and provide an accurate and preferred email contact. This means pharma marketers can have the highest level of acceptance and success through the email channel. DMD has become the recognized leader of email data for strategic pharmaceutical marketing.

WHAT’S NEW AND EXCITING AT DMD?

DMD has patents in process describing a new method of identifying and tracking healthcare professionals across platforms and channels. It will provide publishers and marketers an even better way of targeting, coupled with unique user experiences that can identify new digital marketing opportunities in real-time.

HOW DO YOU SEE DMD AND RELTIO BENEFITING COMPANIES?

Making our HCP preferred email contact data directly available through Reltio Cloud and Reltio data-as-a-service (DaaS) means marketing and sales business teams can have the most accurate and up-to-date email addresses at their fingertips. This is an amazing capability that allows pharmaceutical companies to reach out to their target HCPs at a moments notice.

We plan to collaborate together to provide more actionable datasets through Reltio DaaS in the future. We believe that pharma companies will love taking advantage of this on demand delivery mechanism that combines our reliable email data with relevant insight to achieve better results and better targeted marketing faster.

[midard]

Voici un petit vidéo qui explique le DaaS (Data As A Service)

[midard]

ça bouge encore beaucoup sur le coté des insiders au début du mois de septembre vente et achat Canadianinsider

[midard]

Beaucoup d’achat d’initiés dernièrement

[midard]

Les états financiers sont disponibles sur Sedar. revenue $7,954,000 net income $1,097,000 earning per share .01

Overview for the quarter ended September 30, 2015
Net income for the three‐month period ended September 30, 2015 was $1.1 million compared to a
net income of $0.1 million for the same period a year earlier. With these successive profitable
quarterly results over the last two and a half years and the successful restructuring of its debt, the
Company is anticipating continued growth and expansion for the next twelve months and beyond.
Revenue during the quarter ended September 30, 2015 increased by 69% to $8.0 million, the
Company’s highest quarterly revenue in five years. The Company continued to improve and
expand its data services product offering to consolidate its position as the email communication
channel of choice for healthcare companies to reach professionals through web and mobile
technology. Correspondingly, gross margin increased by 97% to $4.6 million from $2.3 million for the
quarter ended September 30, 2014. Operating expenses excluding depreciation and amortization
were $2.6 million for the three‐month period ended September 30, 2015 compared to $1.4 million
for the same period ended September 30, 2014. As a result, the Company’s operating income for the
quarters ended September 30, 2015 was $1.6 million, an improvement of $1.0 million over the same
quarter a year earlier.
Outlook
With the finalization of the debt settlement with its Canadian lenders realized at the end of June
2015 which generated a gain of $3.1 million, the full repayment of the demand loan of
US$ 1.0 million contracted in 2013, the shares for debt transaction in the amount $361, an unused
multi‐million dollar line of credit and the continued growth in revenue, the Company is in a much
stronger financial position to focus its energy towards improving and expanding its data services
product offering and email database and deployment services. Given that the sales cycle to
engage major manufacturers takes upwards of 18 months, we expect that the gains and efforts
made over the past two years will carry over into 2016 and the following years.

[midard]

Point vue technique, il y a quelque chose qui s’en vient ici. (pas de position)

[midard]

Groupe DMD connexions sante numeriques inc. conclut une entente visant a privatiser la Societe pour une contrepartie en especes ou en actions privilegiees au prix de 0.25 par action